Why Europe must act now to strengthen its Life Sciences industry

Europe has the science, talent and entrepreneurial ambition to lead globally in life sciences. Too often, however, it lacks the capital and market conditions needed to help its most innovative companies scale and stay in Europe. Today, the European Life Sciences Coalition, in association with Invest Europe and supported by more than 200+ investors, companies and research organisations, has published an open letter calling on EU leaders to make life sciences a strategic priority for Europe's competitiveness, resilience and health.

The message is clear: mobilise more long-term capital, deepen European capital markets, simplify regulation and create the conditions for innovation to thrive.

Europe cannot afford to lose its next generation of life sciences champions.

Read the open letter.

The European Life Sciences Coalition (ELSC) was launched in association with Invest Europe on 12 February, 2026. Our members, venture capital investors and research organisations from across the continent, collectively manage more than €25B in Life Sciences-specific assets.